ABLD ABL Texcell Diagnostics SA

EPA · FR · Healthcare · Health Information Services · abldiagnostics.com

2.160EUR-1.82%Mkt Cap: 37.75M $P/E: 18.00Today

ABL Texcell Diagnostics SA provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internation…

Industry Peers

Health Information Services

Tempus AI, Inc. - Class A Common Stock

$13.83BUSD

BTSG

BrightSpring Health Services, Inc. - Common Stock

HealthEquity, Inc. - Common Stock

Waystar Holding Corp. - Common Stock

$4.76BUSDP/E 35.4

HTFL

Heartflow, Inc. - Common Stock

$4.29BUSD

PRVA

Privia Health Group, Inc. - Common Stock

$2.59BUSDP/E 92.3

SDGR

Schrodinger, Inc. - Common Stock

$2.27BUSD

OMCL

Omnicell, Inc. - Common Stock

$1.53BUSDP/E 40.0

CERT

Certara, Inc. - Common Stock

$1.43BUSD

OMDA

Omada Health, Inc. - Common Stock

$1.25BUSDP/E 30.4

GDRX

GoodRx Holdings, Inc. - Class A Common Stock

HealthStream, Inc. - Common Stock

$942.97MUSDP/E 42.8

SOPH

SOPHiA GENETICS SA - Ordinary Shares

Weave Communications, Inc.

$592.12MUSD

RAY-B

RaySearch Laboratories AB (publ)

$523.69MUSDP/E 29.5

Key Statistics

Company

Market Cap37.75M USD

Enterprise Value—

Revenue (TTM)11.45M USD

Gross Profit7.20M USD

Net Income (TTM)1.07M USD

Revenue/Share0.48 EUR

Last Price2.160 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees22

CountryFR

SectorHealthcare

IndustryHealth Information Services

ISINFR001400AHX6

Valuation

P/E (Trailing)18.00

P/E (Forward)—

PEG1.94

EV/EBITDA—

EV/Revenue—

P/S3.36

P/B4.63

EPS (TTM)0.12

EPS (Forward)—

52W Range

2.1002% of range5.000

52W High5.000 EUR

52W Low2.100 EUR

Profitability

Gross Margin95.29%

Oper. Margin20.59%

EBITDA Margin15.28%

Profit Margin14.20%

ROE12.93%

ROA7.62%

Growth

Revenue Growth65.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF1.64M USD

CapEx (TTM)861.60K USD

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.29

Current Ratio—

Quick Ratio—

Book Value/Sh0.47 EUR

Cash/Share—

Dividends

Fwd Div Rate0.11 EUR

Trail. Div Rate0.00 EUR

Div. Yield5.00%

5Y Avg Yield—

Payout Ratio89.43%

Ex-Div DateJul 3, 2026

Pay Date—

Splits

Last Split8:1

Split DateMay 18, 2022

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.16.08M

Float990.04K

Insiders93.57%

Institutions0.00%

Technical

SMA 502.410 (-10.4%)

SMA 2002.896 (-25.4%)

Beta-0.57

S&P 52W Chg14.58%

Avg Vol (30d)5.03K

Avg Vol (10d)4.90K

Technical Indicators

RSI (14)38.7

MACD-0.0584

MACD Signal-0.0325

MACD Hist.-0.0259

BB Upper2.639 EUR

BB Middle2.392 EUR

BB Lower2.145 EUR

BB Width20.66%

ATR (14)0.1258 EUR

Vol Ratio (20d)0.66x